---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-051374"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2024-12-16T23:59:59+00:00"
generated_at: "2026-05-29T02:50:35.823305+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ChromaDex appoints Crowe LLP as new independent auditor effective December 13, 2024

## Summary
- Audit Committee approved Crowe LLP as independent auditor for fiscal year ending Dec 31, 2024, effective Dec 13, 2024.
- No disagreements with prior auditor during fiscal years 2023 and 2022 and subsequent interim period.
- No consultations with Crowe regarding application of accounting principles or audit opinion prior to engagement.
- Change follows competitive request-for-proposal process conducted by Audit Committee.

## SEC filing metadata
- accession: 0001628280-24-051374
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2024-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 4.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000162828024051374/0001628280-24-051374-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000162828024051374/cdxc-20241213.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-051374
- JSON: https://secwatch.observer/filing/0001628280-24-051374.json
- Plain text: https://secwatch.observer/filing/0001628280-24-051374.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.